Related Experiment Video
Updated: Oct 27, 2025

Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on
Johanna Sandor-Keri1, Istvan Benedek2, Stefania Polexa1
1Clinic of Cardiology, University of Medicine, Pharmacy, Science, and Technology, George Emil Palade of Targu Mures, 540139 Targu Mures, Romania.
Insights
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection increases cardiovascular risks. Inflammation and hypercoagulability are key factors, with neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as potential prognostic markers.
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is linked to increased cardiovascular complications and mortality.
- Inflammation and hypercoagulability are implicated in both severe COVID-19 and cardiovascular events like acute myocardial infarction.
Purpose of the Study:
- To review recent findings on the relationship between SARS-CoV-2 infection, inflammation, and blood coagulability.
- To explore the role of these factors in major cardiovascular events.
Main Methods:
- Literature review of studies investigating SARS-CoV-2, cardiovascular diseases, inflammation, and coagulability.
- Analysis of prognostic markers such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).
Main Results:
- SARS-CoV-2 infection elevates cardiovascular risks, particularly in patients with pre-existing heart conditions.
- Inflammation and hypercoagulability are critical pathophysiological links between COVID-19 and cardiovascular events.
- NLR and PLR show potential as independent prognostic markers for COVID-19 severity.
Conclusions:
- Understanding the interplay between SARS-CoV-2, inflammation, and coagulability is crucial for managing cardiovascular risks.
- NLR and PLR may serve as valuable tools for predicting disease severity and outcomes in COVID-19 patients.
Abstract:
The link between severe forms of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection and cardiovascular diseases has been well documented by various studies that indicated a higher risk of cardiovascular complications in COVID-19 patients, in parallel with a higher risk of mortality in COVID-19 patients with underlying cardiovascular diseases. It seems that inflammation, which is a major pathophysiological substrate for both acute myocardial infarction and severe forms of COVID-19, may play a pivotal role in the interrelation between these two critical conditions, and hypercoagulability associated with SARS-CoV-2 infection could be responsible for acute cardiovascular complications. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) proved to be independent predictors for prognosis in acute coronary syndromes and systemic inflammatory diseases; therefore, they may be used as independent prognostic markers of disease severity in COVID-19 infection. The aim of this review is to present the most recent advances in understanding the complex link between SARS-CoV-2 infection, inflammation and alteration of blood coagulability and hemorheology, leading to major cardiovascular events.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction

